Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “DLBCL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05952024
What this trial is testing

Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL

Who this might be right for
Diffuse Large B-Cell Lymphoma
AstraZeneca 80
Testing effectiveness (Phase 2)Looking for participantsNCT06854159
What this trial is testing

Odronextamab for the Treatment of Relapsed and Refractory Diffuse Large B-cell Lymphoma Before and After Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Transformed Follicular Lymphoma to Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+1 more
University of California, Davis 34
Not applicableStudy completedNCT04160442
What this trial is testing

Use of a Patient Preferences Shared Decision-Making Encounter Tool in Clinical Practice for Patients With DLBCL and FL

Who this might be right for
Diffuse Large B Cell LymphomaFollicular Lymphoma
Carevive Systems, Inc. 46
Large-scale testing (Phase 3)Ended earlyNCT00486759
What this trial is testing

Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Hoffmann-La Roche 787
Testing effectiveness (Phase 2)Active Not RecruitingNCT02889523
What this trial is testing

Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy

Who this might be right for
LymphomaDLBCLFollicular Lymphoma
The Lymphoma Academic Research Organisation 214
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Testing effectiveness (Phase 2)Looking for participantsNCT07654426
What this trial is testing

The CARDIOPROTECT Trial

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)CardiotoxicityLymphoma
Beth Israel Deaconess Medical Center 60
Large-scale testing (Phase 3)Active Not RecruitingNCT04404283
What this trial is testing

Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL

Who this might be right for
Diffuse Large B-cell Lymphoma
Seagen, a wholly owned subsidiary of Pfizer 239
Not applicableStudy completedNCT01715961
What this trial is testing

Clinical and Prognostic Value of Sarcopenia in Patients Older Than 70 Years With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell LymphomaGrade IIIB Follicular Lymphoma
Centre Henri Becquerel 98
Testing effectiveness (Phase 2)Looking for participantsNCT07288879
What this trial is testing

DALY II Japan/MB-CART2019.1 for DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaCAR T Cell Therapy
Miltenyi Biomedicine GmbH 31
Early research (Phase 1)Active Not RecruitingNCT06014762
What this trial is testing

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh-grade B-cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+7 more
Poseida Therapeutics, Inc. 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06890585
What this trial is testing

Zanubrutinib, Chidamide, and Rituximab Induction With or Without CHOP Versus R-CHOP in Newly Diagnosed Double-Expressor DLBCL

Who this might be right for
BTK InhibitorsHistone Deacetylase InhibitorDouble Express Diffuse Large B-cell Lymphoma
Li Zhiming 128
Not applicableActive Not RecruitingNCT01829958
What this trial is testing

Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy

Who this might be right for
Non Hodgkin Lymphoma (NHL)Diffuse Large B-cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center 201
Testing effectiveness (Phase 2)Study completedNCT00379574
What this trial is testing

Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCL

Who this might be right for
Lymphoma, Large-Cell, DiffuseLymphoma, B-Cell
Asan Medical Center 49
Early research (Phase 1)Ended earlyNCT05144347
What this trial is testing

Study of XL114 in Subjects With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ABC-DLBCL)Mantle Cell Lymphoma (MCL)+2 more
Exelixis 2
Testing effectiveness (Phase 2)Looking for participantsNCT06158399
What this trial is testing

AZA Combined With RCHOP in P53-mutated DLBCL.

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaTP53
The First Affiliated Hospital of Xiamen University 52
Not applicableNot Yet RecruitingNCT06573099
What this trial is testing

A Real-World Study on Extranodal Lymphoma

Who this might be right for
LymphomaLymphoma, B-CellLymphoma, Non-Hodgkin+2 more
Ruijin Hospital 5,000
Not applicableLooking for participantsNCT02964858
What this trial is testing

Radiation Dose Optimization in Diffuse Large B- Cell Lymphoma.

Who this might be right for
NonHodgkin Lymphoma
Tata Memorial Hospital 840
Testing effectiveness (Phase 2)Study completedNCT00622388
What this trial is testing

Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant

Who this might be right for
Lymphoma, Large-Cell, Diffuse
GlaxoSmithKline 81
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677813
What this trial is testing

Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Ou Bai, MD/PHD 66
Next Page